期刊文献+

强化治疗对初诊2型糖尿病β细胞功能影响的研究 被引量:4

Study on the influence of intensive treatment on B cell function of newly-diagnosed type 2 diabetes mellitus
下载PDF
导出
摘要 目的:探讨二种不同疗法对2型糖尿病β细胞功能的影响。方法:将100例初诊2型糖尿病患者分为二组:强化治疗组和口服药组。强化组用胰岛素泵连续皮下输注,使血糖完全达标。强化治疗15 d后停止皮下连续输注。口服药组口服降糖药物,使血糖达标。患者均在治疗前测体重,空腹血糖,空腹胰岛素水平,糖化血红蛋白,馒头餐试验检测0、0.5 h、2h胰岛素水平,并计算空腹胰岛素/空腹血糖。3个月后复查上述指标。结果:强化治疗组空腹胰岛素/空腹血糖值,0.5 h胰岛素水平有明显升高(P<0.05),口服药组空腹胰岛素/空腹血糖值,0.5 h胰岛素水平无明显改变,而2 h胰岛素水平有明显升高(P<0.05)。结论:皮下连续输注治疗可使血糖,糖化血红蛋白控制的更好,空腹胰岛素/空腹血糖0.5h胰岛素水平明显升高。皮下连续输注强化治疗使β细胞功能恢复,而口服药组胰岛素释放延迟更明显,加重β细胞负担,不利于β细胞功能的恢复。 Objective To study the influence of 2 kinds of treatments on B cell function of T2DM. Methods One hundred newly-diagnosed type 2 diabetic patients were divided into intensive treatment group and orally taking medicine group. Intensive treatment group received insulin pump subsutaneous injection continuously till the blood glucose reaching standard. After 15 days treatment the subsutareous injection was stopped orally taking medicine group received medicine orally till the blood glucose reaching standard. Before treatments, the body temperature FPG, FINS, HbA1C of all the patients were measured,the test of food was given in 0,0. 5 h,2 h to detect insulin level,and calculate the FINS/FPG. After 3 months,re-exam the obove indices. Results In intensive treatment group the FINS/FPG,0.5 h insulin level rised obviously and did not change obviously in orally takinginedicine group. But 2 h insulin level rised obviously (P<0.05). Conclusion Continuous subcutaneous injection can control the blood glucose. HbA1C better,FINS/FPG and 0. 5 h insulin level rise obviously. The intensive treatment of subcutaneous injection can restore B cell function. In taking medicine group, insulin releases slowly. It makes the burden of B cell heavier. It's not good to the restore of B cell function.
出处 《实用诊断与治疗杂志》 2005年第1期14-15,共2页 Journal of Practical Diagnosis and Therapy
关键词 强化治疗 2型糖尿病 Β细胞功能 Intensive treatment type 2 diabetes mellitus B cell function
  • 相关文献

参考文献7

  • 1李光伟,潘孝仁.空腹血胰岛素、葡萄糖比值作为β细胞功能指数的可能性[J].中华内分泌代谢杂志,1998,14(4):232-235. 被引量:45
  • 2Prigeon R J,Jacobson R K,Porte D,et al. Effect of sulfonylurea withdrawal on proinsulin levels, B-cell function, and glucose disposal in subjects with non-insulin-dependent diabetes mellitus[J]. J Clin Endocrinol Metab,1996,81:3295.
  • 3Davies M J,Metcalfe J,Day J L,et al. Effect of sulphonylurea therapy on plasma insulin, intact ang 32/33. split proinsulin in subjects with type 2 diabetes mellitus[J]. Diabet Med, 1994,11:293.
  • 4Raehman J, Levy J C, Barrow B A, et al. Relative yperproinsulinemia of NIDDM persists despite the reduetion of hyperglycemia with insulin or sulfonylurea therapy[J]. Diabetes,1997,46:1557.
  • 5Stone L M,Kahn S E,Fujimoto W Y,et al. A variation at position 30 of the B-cell gluckonase gene promoter is associated with reduced b-cell function in middle-aged Japaness-American men[J]. Diabetes, 1999,45 : 42.
  • 6Holman R R,Robert Turner,Rury Holman, et al. UKPDS Study[J]. Diabetes Care, 1999,22 : 966.
  • 7Del Prato S, Tiengo A. The importance of first-phase insulin secretion :implications for the therapy of type 2 diabetes mellitus[J]. Diabetes Metab Res Rev,2001,17(3) : 164.

二级参考文献3

  • 1潘孝仁,Diabetes Care,1997年,20卷,537页
  • 2李光伟,中华内科杂志,1993年,33卷,656页
  • 3刚勇,中华内分泌代谢杂志,1989年,5卷,173页

共引文献44

同被引文献29

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部